Walleye Trading
TVRD

Walleye Trading’s Tvardi Therapeutics TVRD Stock Holding History

Walleye Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-442
Closed -$171K – 5523
2022
Q4 		$171K Buy
+442
New +$168K ﹤0.01% 3689
2022
Q2 		– Sell
-400
Closed -$175K – 5787
2022
Q1 		$175K Buy
400
+281
+236% +$115K ﹤0.01% 3903
2021
Q4 		$52K Sell
119
-59
-33% -$29.6K ﹤0.01% 4667
2021
Q3 		$99K Buy
+178
New +$89.3K ﹤0.01% 4367
2020
Q2 		– Sell
-83
Closed -$40K – 4682
2020
Q1 		$40K Buy
+83
New +$45.1K ﹤0.01% 3486
2019
Q2 		– Sell
-164
Closed -$116K – 4591
2019
Q1 		$116K Sell
164
-186
-53% -$111K ﹤0.01% 3386
2018
Q4 		$164K Sell
350
-511
-59% -$330K ﹤0.01% 3569
2018
Q3 		$742K Buy
+861
New +$622K ﹤0.01% 2438

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's TVRD Position: Q2 2022 in Review

Walleye Trading sold out of Tvardi Therapeutics (TVRD) in Q2 2022, closing a stake of 284 shares — an estimated $124K sold.

Walleye Trading first reported a position in TVRD in Q3 2015 and held it in 4 quarters. The position peaked at $164K in Q4 2018. 178 funds tracked by Wall St. Rank hold TVRD as of Q2 2022.

  • Walleye Trading reported no remaining Tvardi Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 284 Tvardi Therapeutics shares in Q2 2022, an estimated $124K.
  • Walleye Trading first reported a position in Tvardi Therapeutics in Q3 2015 and held it in 4 quarters.
  • Walleye Trading's Tvardi Therapeutics position peaked at $164K in Q4 2018.
  • 178 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.